Crescent Biopharma Stock (NASDAQ:CBIO)
Previous Close
$13.08
52W Range
$9.81 - $37.00
50D Avg
$12.45
200D Avg
$18.06
Market Cap
$184.01M
Avg Vol (3M)
$106.76K
Beta
1.49
Div Yield
-
CBIO Company Profile
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.